GENE ONLINE|News &
Opinion
Blog

2018-06-01| Technology

2018 ASCO Annual Meeting Opens in Chicago

by GeneOnline
Share To

The American Society of Clinical Oncology (ASCO) hosts the 2018 Annual Meeting in theMcCormick Place Convention Centre in Chicago, IL, on June 1-5.

By Joanne Shih

The meeting attracts more than 39,000 attendees, including over 32,000 oncology professionals, from around the world to discuss the latest advances in oncology and together to create innovative solution for cancer patients.

This year, the focus of the meeting is precision medicine. Setting the 2018 Meeting apart from the previous gathering, Dr. Bruce E. Johnson, MD, President of the 2017-2018 ASCO, defines the main theme as “Delivering Discoveries: Expanding the Reach of Precision Medicine” to address a need of making precision medicine accessible to all cancer patients.

Dr. Johnson remarked, “Precision medicine is transforming cancer care in profound ways and is a focus of this year’s meeting. I firmly believe that the number of patients who benefit from precision medicine will continue to increase as treatments become more effective.”

More than 6,450 research abstracts and 2,515 oral abstracts will be presented through out this five-day meeting. Abstracts selected by the Scientific Program Committee as having practice-changing discoveries will be presented in the Plenary Session. Aside from the Plenary Session, there will be other sessions, including Education Sessions, Clinical Problems in Oncology Sessions, Oral Abstract Sessions, Poster Sessions, respectively covering different topics. The ASCO also offers various of workshops and business connection for professionals to interact and generate more opportunities from bench to bed.

Reference
https://am.asco.org
https://am.asco.org/sites/am.asco.org/files/AM18-Proceedings-Full.pdf

 

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
ASCO 2022: AstraZeneca, Pfizer, Novartis Share Key Data on Breast Cancer Therapeutics
2022-06-07
Everest and Gilead Announce Positive Phase 3 Results of Breast Cancer Drug
2022-06-06
Extracting Clinical Information from Cancer Genomics
2021-06-10
LATEST
Pfizer To Invest $1.26 Billion In Irish Plant, Forms New Vant Company Targeting Inflammation
2022-12-02
Scientists Identify New Genetic Variant Related to Obesity
2022-12-01
Micronbrane Medical Aspires to Further Clinical Collaboration Following the Successful Series A Funding
2022-12-01
FDA Revokes Authorization Of Eli Lilly’s COVID-19 Antibody
2022-12-01
Eisai Unveils Lecanemab Data Following Reports of Second Alzheimer’s Patient Death
2022-11-30
New CRISPR/Cas9 license agreement for ERS Genomics and Cosmo Bio
2022-11-30
Gland Pharma Dispels Rumors Of Fosun Sale, Acquires Cenexi In Separate Development
2022-11-30
EVENT
2022-12-10
64TH ASH ANNUAL MEETING & EXPOSITION
New Orleans, USA
2022-12-14
BIOHK2022
Hong Kong, China
2023-01-07
7th Asia Microbiome Conference
Taipei, Taiwan
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!